S10 - "Best Of" Session: MS and CNS Inflammatory Disease

Event Time: Monday April 24, 2017 8:00 am to 9:00 am
Topic(s): MS and CNS Inflammatory Disease
Description: A platform session that brings together the top four scoring abstracts in a particular topic, as rated by the topic reviewers. Offers an opportunity to interact with the author in a smaller setting at the conclusion of the session.
Completion Message:
CME Credits: 1
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
8:00 AM 001 Longitudinal characterization of cortical lesion evolution in multiple sclerosis by ultra high field MRI Constantina A Treaba
Dr. Treaba has nothing to disclose.

8:08 AM 002 Durable Reduction in MRI Disease Activity With Alemtuzumab in the Absence of Continuous Treatment in Patients With Active Relapsing-Remitting Multiple Sclerosis Who Were Treatment-Naive: 6-Year Follow-up of the CARE-MS I Study Douglas L Arnold, MD
Dr. Arnold has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acorda, Biogen, F. Hoffmann-La Roche Ltd, MedDay, MedImmune, Mitsubishi, Novartis, Receptos/Celgene, Sanofi-Aventis. Dr. Arnold has received compensation for serving on the Board of Directors of NeuroRx Research.

8:16 AM 003 Environmental risk factors associated with pediatric MS: The role of remote viral infections and vitamin D revisited. Shayandokht Taleb, MD
Dr. Taleb has nothing to disclose.

8:24 AM 004 Self-reported fatigue and lower limb problems predictive of conversion to secondary progressive multiple sclerosis in an aging sample of patients Caila Vaughn
Dr. Vaughn has nothing to disclose.

Register Now

Related Courses